ATE368858T1 - Verfahren zur diagnose von transmissiblen spongiformen encephalopathien - Google Patents

Verfahren zur diagnose von transmissiblen spongiformen encephalopathien

Info

Publication number
ATE368858T1
ATE368858T1 AT01931527T AT01931527T ATE368858T1 AT E368858 T1 ATE368858 T1 AT E368858T1 AT 01931527 T AT01931527 T AT 01931527T AT 01931527 T AT01931527 T AT 01931527T AT E368858 T1 ATE368858 T1 AT E368858T1
Authority
AT
Austria
Prior art keywords
fabp
ami
spongiform encephalopathies
transmissible spongiform
cjd
Prior art date
Application number
AT01931527T
Other languages
English (en)
Inventor
Denis Francois Hochstrasser
Jean-Charles Sanchez
Catherine Gabrielle Zimmermann
Elisabeth Guillaume
Original Assignee
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005683A external-priority patent/GB2360089A/en
Application filed by Univ Geneve filed Critical Univ Geneve
Application granted granted Critical
Publication of ATE368858T1 publication Critical patent/ATE368858T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Eye Examination Apparatus (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01931527T 2000-03-10 2001-03-12 Verfahren zur diagnose von transmissiblen spongiformen encephalopathien ATE368858T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0005683A GB2360089A (en) 2000-03-10 2000-03-10 Diagnostic assay for transmisible spongiform encephalopathies
GB0006064A GB0006064D0 (en) 2000-03-10 2000-03-14 Diagnostic assay for transmissable spongiform encephalopathies

Publications (1)

Publication Number Publication Date
ATE368858T1 true ATE368858T1 (de) 2007-08-15

Family

ID=26243824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931527T ATE368858T1 (de) 2000-03-10 2001-03-12 Verfahren zur diagnose von transmissiblen spongiformen encephalopathien

Country Status (9)

Country Link
US (1) US7368247B2 (de)
EP (1) EP1261875B1 (de)
JP (1) JP4575635B2 (de)
AT (1) ATE368858T1 (de)
AU (2) AU5828201A (de)
CA (1) CA2402314C (de)
DE (1) DE60129674T2 (de)
DK (1) DK1261875T3 (de)
WO (1) WO2001067108A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
WO2003012445A1 (en) * 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US8450071B2 (en) 2002-03-08 2013-05-28 The Board Of Regents Of The University Of Oklahoma Biomarker and method for detecting a chronic inflammatory-associated disease
US7655480B2 (en) * 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
WO2003092601A2 (en) * 2002-04-30 2003-11-13 Seikagaku Corporation A method for detecting lysosomal storage diseases
EP2211181A1 (de) 2002-10-30 2010-07-28 Proteome Sciences Plc Methoden um übertragbare Spongiforme Enzephalopathien zu diagnostizieren
CA2532130C (en) * 2003-09-20 2016-07-19 Electrophoretics Limited Diagnostic method for brain damage-related disorders
CN100422742C (zh) * 2005-05-16 2008-10-01 艾博（武汉）生物技术有限公司 急性心肌梗死早期诊断三合一检测试剂板
GB2428240A (en) * 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
US7399598B2 (en) * 2005-10-14 2008-07-15 Taipei Medical University Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
US20070161074A1 (en) * 2005-12-27 2007-07-12 Daiichi Pharmaceutical Co., Ltd. Diagnostic method of mucopolysaccharidoses
US7645616B2 (en) * 2006-10-20 2010-01-12 The University Of Hong Kong Use of lipocalin-2 as a diagnostic marker and therapeutic target
NL1033365C2 (nl) * 2007-02-09 2008-08-12 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
US9399675B2 (en) 2007-02-28 2016-07-26 The Board Of Regents Of The University Of Oklahoma Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
JP2008241387A (ja) * 2007-03-27 2008-10-09 Chube Univ メタボリックシンドロームの予知検査方法
NL2001577C2 (nl) * 2008-05-14 2009-11-17 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
CN102725636B (zh) 2009-12-20 2015-04-01 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
US9347941B2 (en) * 2012-01-13 2016-05-24 Catholic University Industry-Academic Cooperation Foundation Diagnosis kit for rheumatoid arthritis
RU2522231C1 (ru) * 2012-11-14 2014-07-10 Евгений Иосифович Гоуфман Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
EP3509646A4 (de) 2016-09-09 2020-06-17 Mayo Foundation for Medical Education and Research Verfahren und materialien zur identifizierung und behandlung von autoimmuner gfap-astrozytopathie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3012666B2 (ja) * 1990-05-28 2000-02-28 大日本製薬株式会社 心筋梗塞の判定方法
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
GB2319607A (en) 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
EP0861900A1 (de) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunologischer Nachweis von Prionen
AU6894298A (en) 1997-04-08 1998-10-30 Incyte Pharmaceuticals, Inc. Human fatty acid binding protein
FR2763692B1 (fr) * 1997-05-22 1999-07-09 Agronomique Inst Nat Rech Diagnostic in vitro des encephalopathies subaigues spongiformes transmissibles, par dosage de metabolites du cortisol
CA2206774A1 (en) * 1997-06-16 1998-12-16 Rick E. Preddie "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke

Also Published As

Publication number Publication date
DK1261875T3 (da) 2007-11-26
WO2001067108A2 (en) 2001-09-13
AU5828201A (en) 2001-09-17
CA2402314A1 (en) 2001-09-13
DE60129674D1 (de) 2007-09-13
WO2001067108A3 (en) 2002-03-21
JP2003526788A (ja) 2003-09-09
US20030157580A1 (en) 2003-08-21
CA2402314C (en) 2009-12-08
AU2001258282B2 (en) 2005-05-05
DE60129674T2 (de) 2008-06-05
US7368247B2 (en) 2008-05-06
EP1261875A2 (de) 2002-12-04
JP4575635B2 (ja) 2010-11-04
EP1261875B1 (de) 2007-08-01

Similar Documents

Publication Publication Date Title
DE60129674D1 (de) Verfahren zur diagnose von transmissiblen spongiformen encephalopathien
DE60034480D1 (de) Diagnostischer assay für schlaganfall
US8481274B2 (en) Methods and kits for separation and detection of proteins in biological samples
ATE360433T1 (de) Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose
ATE300051T1 (de) Test zum nachweis von prionen-proteinen die in einer mit krankheit assoziierten konformationen vorliegen
DE10303974A1 (de) Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE69733560D1 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
DK1571970T3 (da) Diagnose og monitorering af sygdomme
EA199800460A1 (ru) Диагностика и медиаторы воспалительных нарушений
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
US6255060B1 (en) Method of detecting protein by immuno RNA
EA200101021A1 (ru) Способ диагностики трансмиссивных губчатых энцефалопатий
EP4685489A3 (de) Assay für mybpc3
DE60226125D1 (de) Verfahren zur quantifizierung von glykiertem protein
AU2001287423A1 (en) Methods and kits for separation and detection of proteins in biological samples
FI885312L (fi) Menetelmä spesifisesti sitovan proteiinin ja vastaavan sidottavan aineen välisen reaktion yhden tai useamman komponentin määrittämiseksi koenäytteestä käyttäen ainakin yhtä leimattua komponenttia, menetelmä leimatun komponentin valmistamiseksi sekä koepakkaus.......
WO2002099434A3 (de) Verwendung von 14-3-3-proteinen und verfahren zu deren bestimmung in flüssigkeiten oder geweben von organismen
US20020197741A1 (en) Method of determining time of death
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
JPH07504165A (ja) カゼインマクロペプチドのペプチド類，これらペプチド類の抗体と用途
DE3870035D1 (de) Biologisches diagnostisches testsystem.
He et al. An immunoprecipitation coupled with fluorescent Western blot analysis for the characterization of a model secondary serum cardiac troponin I reference material
DE69921107D1 (de) Verfahren zur messung der knochenresorptionsrate
WO2005001481A1 (de) Nachweise von protease-resistentem prion-protein nach spontaner transformationsreaktion